The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium.  Arbli, an angiotensin II receptor blocker, is indicated for the treatment of ...

The global burden of diabetic nephropathy increased from 1990 to 2021, and is projected to continue increasing to 2050.

HOLDINGS has completed a draw on its Equity Line of Credit to support the commercial launch of Arbli Oral Suspension, while ...

Given the success of the previous collection Diagnosis, Prevention and Treatment in Diabetic Nephropathy - Volume II, and the new advances in the field, we ...

The following is a summary of “Lipid abnormality in diabetic kidney disease and potential treatment advancements,” published ...

Worried about diabetes and kidney damage Find out how high blood sugar affects your kidneys and steps to safeguard your ...

Depressive and anxiety symptoms tied to progression to kidney failure in patients with diabetic nephropathy suggests a study ...

Scienture (SCNX) announces the U.S. Food and Drug Administration, FDA, has approved SCN-102, one of the products being developed by Scienture, ...

Chronic kidney disease, also called End Stage Renal Failure, describes the gradual loss of kidney function. The kidneys filter waste and excess fluids from the blood, which is then excreted ...

The global burden of diabetic nephropathy increased from 1990 to 2021, and is projected to continue increasing to 2050, ...

The global burden of diabetic nephropathy increased from 1990 to 2021, and is projected to continue increasing to 205 ...

Srinagar- Cases of Chronic Kidney Disease (CKD) have doubled in the past decade in India and Jammu & Kashmir, caused by ...